Fingerprint
Dive into the research topics of 'Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
The ADvocate1 and ADvocate2 Investigators
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations